Milestone Scientific MLSS 深 沪
等待开盘 10-30 09:30:00 美东时间
0.4457
-0.012
-2.71%
华盛通- 最 高0.4801
- 今 开0.455
- 成交量 10.45万股
- 最 低 0.4457
- 昨 收 0.4581
- 总市值 3497.73万
- 52周最高 1.3926
- 市盈率 静 --
- 换手率 0.13%
- 52周最低 0.3753
- 委 比 -94.17%
- 总股本 7847.73万
- 历史最高 4.853
- 量 比 0.65
- 振 幅 7.51%
- 历史最低 0.26
- 每 手 1
- 风险率 0.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Milestone Scientific receives NYSE American non-compliance notification
Milestone Scientific (NYSE:MLSS) on Tuesday said it has received a letter from NYSE American, stating that the company is not in compliance with the continued listing standards. The rules require a li...
10-14 20:28
Milestone Scientific Faces NYSE Non-Compliance Notice
Milestone Scientific ( ($MLSS) ) has issued an announcement. On October 8, 2025...
10-14 20:24
Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership
Milestone Scientific Inc. CEO Eric Hines has implemented strategic initiatives to accelerate growth, strengthen market position, and improve efficiency across its dental and medical segments. Key actions include expanding sales programs, enhancing digital marketing, and securing international registrations. The company has reduced operating expenses by 20% in Q3, driven by increased interest in CompuFlo® and STA®. These efforts aim to boost both ...
10-14 11:50
Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification
Milestone Scientific Inc. received a letter from NYSE American stating it doesn't meet listing standards due to insufficient shareholders’ equity and five consecutive years of losses. The company has 30 days to submit a compliance plan, aiming to regain listing by April 2027. CEO Eric Hines expressed confidence in恢复 compliance through revenue growth and cost management. The company’s stock trading remains unaffected, but continued listing depends...
10-14 11:45
Milestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain Management
Milestone Scientific appoints Dawood Sayed, M.D., a leading pain medicine expert, to its Board of Directors, enhancing its expertise in expanding CompuFlo® adoption in interventional pain management. Dr. Sayed brings extensive clinical and policy experience, advancing the company's goals to improve patient outcomes and reduce opioid reliance. His leadership will support commercial growth and payer adoption of the innovative CompuFlo® Epidural Sys...
09-22 13:15
Milestone Scientific Reports Increased Sales but Faces Losses
Milestone Scientific Inc ( ($MLSS) ) has released its Q2 earnings. Here is a br...
08-16 11:54
Milestone Scientific shares are trading higher. The company reported Q2 financial results.
Milestone Scientific shares are trading higher. The company reported Q2 financi...
08-16 01:41
Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025
Milestone Scientific Inc. reported a 25% revenue increase to $2.3 million in Q2 2025, driven by strong international dental sales. The company strengthened its leadership with Eric Hines as CEO, Jason Papes as Global Head of Sales and Marketing, and Shanth Thiyagalingam on the Board. Dental revenue grew due to the STA® system success, while medical revenue rose with CompuFlo® Epidural System adoption in healthcare institutions. Milestone aims to ...
08-14 20:15
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
Milestone Scientific Inc. (MLSS) announced a conference call on August 15, 2025, to discuss its second-quarter 2025 financial results and corporate progress. Call details: US callers dial 888-506-0062, international callers dial +1 973-528-0011, access code 470429. A webcast and replay are available at [link]. Milestone develops innovative injection technologies for medical, dental, and cosmetic applications using its DPS Dynamic Pressure Sensing...
08-13 15:45
